Dr. Maya Viavant, MD

Dr. Viavant practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Viavant's NPI, 1336511849, was assigned on October 23, 2015. Dr. Viavant graduated from UC Davis School of Medicine in 2017. Dr. Viavant holds California license A173252.

Dr. Viavant's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Viavant's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Viavant is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Viavant to 1 more hospital and 1 medical group, each named with a free account. Dr. Viavant's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Viavant practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Viavant's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Viavant is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Viavant's licenses on file in 2 states: California and New York.

CMS data shows 90 Medicare services from Dr. Viavant across 5 procedure codes in 2024, for 105 Medicare patients. Medicare paid $3,428 for them.

CMS counts 105 Medicare patients who saw Dr. Viavant in 2024. The largest group is 65 to 74, with 43 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Viavant's median patient age at 61, with 55% women.

In 2024, Dr. Viavant wrote 98 Medicare Part D claims for 33 patients. 47% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $869 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Viavant for performance year 2024, reported as part of a group. Dr. Viavant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Viavant as offering telehealth.

Dmand AI links 1 paper to Dr. Viavant in 2021. Dr. Viavant's most frequent co-authors are Jennifer Inhae Lee, MD, Mark A. Sonnick, MD and Meredith L. Turetz, MD.

CMS Open Payments shows 1 general payment to Dr. Viavant from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $27.

Dr. Viavant graduated from UC Davis School of Medicine in 2017.

Dr. Viavant is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.